Lexicon Pharmaceuticals Inc (LXRX)
1.63
+0.01
(+0.62%)
USD |
NASDAQ |
Apr 18, 16:00
1.63
0.00 (0.00%)
After-Hours: 20:00
Lexicon Pharmaceuticals Price to Book Value: 4.311 for April 18, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 4.311 |
| April 17, 2024 | 4.284 |
| April 16, 2024 | 4.483 |
| April 15, 2024 | 4.945 |
| April 12, 2024 | 5.210 |
| April 11, 2024 | 5.368 |
| April 10, 2024 | 5.342 |
| April 09, 2024 | 5.474 |
| April 08, 2024 | 5.527 |
| April 05, 2024 | 5.448 |
| April 04, 2024 | 5.448 |
| April 03, 2024 | 5.395 |
| April 02, 2024 | 5.844 |
| April 01, 2024 | 6.030 |
| March 28, 2024 | 6.347 |
| March 27, 2024 | 5.792 |
| March 26, 2024 | 5.236 |
| March 25, 2024 | 5.606 |
| March 22, 2024 | 5.977 |
| March 21, 2024 | 6.373 |
| March 20, 2024 | 6.585 |
| March 19, 2024 | 6.453 |
| March 18, 2024 | 6.664 |
| March 15, 2024 | 6.876 |
| March 14, 2024 | 6.426 |
| Date | Value |
|---|---|
| March 13, 2024 | 6.559 |
| March 12, 2024 | 6.664 |
| March 11, 2024 | 7.431 |
| March 08, 2024 | 5.739 |
| March 07, 2024 | 5.686 |
| March 06, 2024 | 5.761 |
| March 05, 2024 | 5.919 |
| March 04, 2024 | 5.813 |
| March 01, 2024 | 6.524 |
| February 29, 2024 | 6.550 |
| February 28, 2024 | 6.866 |
| February 27, 2024 | 6.892 |
| February 26, 2024 | 6.418 |
| February 23, 2024 | 6.681 |
| February 22, 2024 | 6.234 |
| February 21, 2024 | 6.602 |
| February 20, 2024 | 6.971 |
| February 16, 2024 | 8.365 |
| February 15, 2024 | 9.417 |
| February 14, 2024 | 8.733 |
| February 13, 2024 | 7.707 |
| February 12, 2024 | 7.681 |
| February 09, 2024 | 6.287 |
| February 08, 2024 | 6.050 |
| February 07, 2024 | 5.656 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.393
Minimum
Sep 25 2023
9.417
Maximum
Feb 15 2024
4.037
Average
3.748
Median
Aug 06 2021
Price to Book Value Benchmarks
| Novavax Inc | -- |
| AIM ImmunoTech Inc | 2.493 |
| Perspective Therapeutics Inc | 11.48 |
| Protalix BioTherapeutics Inc | 2.459 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 298.91 |
| PEG Ratio | -0.0654 |
| Price | 1.63 |
| Earnings Yield | -49.08% |
| Market Cap | 401.37M |
| PEGY Ratio | -0.0654 |